Acute myeloid leukemia
|
Elevated MPs levels; decreased during chemotherapy and increased during remission;elevated CXCR4+- MPs; elevated PMPs and myeloblast-derived MPs
|
Kalinkovich et al., 2006; Szczepanski et al., 2011; Van Aalderen et al., 2011
|
Acute lymphoid leukemia
|
MPs in bone marrow aspirate
|
Savasan et al., 2004
|
Acute promyelocytic leukemia
|
Elevated CD33+TF+ MPs
|
Ma et al., 2013
|
B-cell chronic lymphoid leukemia
|
Elevated MPs levels
|
Ghosh et al., 2009
|
Bladder cancer
|
Elevated MPs containing EGFR-associated proteins
|
Smalley et al., 2008
|
Brain cancer
|
TF+ MPs not elevated
|
Thaler et al., 2012
|
Breast cancer (getting endocrine therapy)
|
Elevated MPs levels;
|
Liebhardt et al., 2010; Trappenburg et al., 2011
|
Elevated annexin V+, CEA-, BCRP-, HSP27+ subpopulations of MPs
|
Breast cancer (metastatic)
|
Elevated TF+ MPs levels;
|
Tesselaar et al., 2007; Toth et al., 2008; Liebhardt et al., 2010
|
Elevated PMPs and annexin V+-MPs; increased annexin V+, CD66+, BCRP1+ and HSP27+ MPs
|
Colorectal cancer
|
Elevated TF+ MPs levels
|
Hron et al., 2007
|
Gastric cancer
|
Elevated MPs and PMPs levels
|
Kim et al., 2003; Baran et al., 2010
|
Glioblastoma multiforme
|
Elevated procoagulant MPs
|
Sartori et al., 2011
|
Gynecological cancer
|
MPs levels are not elevated
|
Zahra et al., 2011
|
Hepatocellular carcinoma
|
Elevated MPs levels
|
Brodsky et al., 2008
|
Lung cancer
|
Elevated MPs levels
|
Kanazawa et al., 2003
|
Non-small cell lung cancer
|
Elevated AnnexinV+-MPs
|
Fleitas et al., 2012
|
Melanoma
|
Elevated MPs levels
|
Lima et al., 2011
|
Multiple myeloma
|
Elevated MPs levels
|
Auwerda et al., 2011
|
Ovarian cancer
|
Elevated MPs levels; elevated CD63+ MPs comparing with benign ovarian tumors; Elevated EpCam + MPs in ascites at advanced stage
|
Ginestra et al., 1999; Taylor et al., 2002; Taylor, Gercel-Taylor, 2008; Rank et al., 2012; Press et al., 2012
|
Ovarian cancer (ascites)
|
Elevated epithelial cell adhesion molecule-positive MPs at advanced stages
|
Press et al., 2012
|
Pancreas cancer
|
Elevated TF+ MPs
|
Thaler et al., 2012
|
Prostate cancer
|
Elevated TF+ MPs; elevated MPs levels
|
Haubold et al., 2009; Coumans et al., 2010
|
Different tumor types
|
Elevated procoagulant MPs levels
|
Manly et al., 2010; Thaler et al., 2011
|
Cancer with thromboembolic complications
|
Elevated MPs levels
|
Zwicker JI et al., 2009
|
Tumor surgery (tumor mass removal)
|
MPs decreased
|
Zwicker et al., 2009; Sartori et al., 2011
|